Beta-neoendorphin is a nine-residue opioid peptide from prodynorphin, closely related to α-neoendorphin and dynorphin B. The pair illustrates how a single precursor is sliced into a panel of subtly different κ-receptor messages.
Cut from prodynorphin by the same convertases that release the dynorphins; α- and β-neoendorphin differ only in their final residues.
Prodynorphin-derived peptides occur in neural tissues; precursor expression alone does not establish co-release of every processed peptide.
Proteolytic processing can generate shorter products; a single fixed circulating half-life is not established by the precursor sequence record.
The reviewed human PDYN record maps α-neoendorphin to precursor residues 175–184 and β-neoendorphin to 175–183. Thus the two peptides differ by one terminal lysine, rather than being two ten-residue sequences. Both begin with the five-residue Leu-enkephalin motif. These coordinates identify the molecules directly and distinguish their sequences from the longer dynorphin peptides produced elsewhere in the same precursor.
Mechanism of Action
κ-preferring agonism with mixed κ/δ affinity — the canonical opioid Gi/o inhibition of transmitter release (opioid receptors, signaling). The pharmacological differences between α- and β-neoendorphin are subtle: same address, slightly different key.
Physiological Effects
The broader dynorphin and κ-receptor system is studied in pain pathways; effects of an individual peptide depend on the experimental model.
The dynorphin–κ-receptor system modulates stress-related behaviour and dopamine circuits; those system-level findings do not establish a separate role for β-neoendorphin.
Its specific contributions to neurohypophyseal hormone release require peptide-specific evidence.
Shares the N-terminal Leu-enkephalin sequence with Leu-enkephalin; the rest of the chain contributes to its distinct receptor pharmacology.
The family relationship does not make the individual peptides interchangeable. A study of the combined dynorphin–κ-receptor system can establish a circuit-level effect without identifying which processed peptide supplied it. Sequence-specific measurements and receptor assays are therefore needed when attributing a particular effect to one neoendorphin. This matters when comparing tissue extracts, precursor-gene expression and experiments using a single synthetic peptide.
When It Goes Wrong
The dynorphin–κ-receptor system is investigated in stress and neuropsychiatric disorders; findings for the system should not automatically be assigned to β-neoendorphin.
Measuring individual processed peptides can help distinguish them from changes in prodynorphin gene expression.